{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:58:22Z","timestamp":1777319902105,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10067-019-04621-2","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T14:02:55Z","timestamp":1559311375000},"page":"2803-2809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["sICAM-1 as potential additional parameter in the discrimination of the Sj\u00f6gren syndrome and non-autoimmune sicca syndrome: a pilot study"],"prefix":"10.1007","volume":"38","author":[{"given":"Auks\u0117","family":"Zinkevi\u010dien\u0117","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Dumalakien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mieliauskait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Vilien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ieva","family":"Narkevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irut\u0117","family":"Girkontait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"4621_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sj\u00f6gren\u2019s Syndrome (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"4621_CR2","doi-asserted-by":"publisher","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M (2016) Sj\u00f6gren\u2019s syndrome. Nat Rev Dis Primers 2. \n                    https:\/\/doi.org\/10.1038\/nrdp.2016.47","DOI":"10.1038\/nrdp.2016.47"},{"key":"4621_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/art.21990","volume":"55","author":"J Champey","year":"2006","unstructured":"Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Berg\u00e9 E, Pellet J, Hardy P, Mariette X (2006) Quality of life and psychological status in patients with primary Sj\u00f6gren\u2019s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 55:451\u2013457","journal-title":"Arthritis Rheum"},{"key":"4621_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2796.2008.02028.x","volume":"264","author":"R Rosenquist","year":"2008","unstructured":"Rosenquist R (2008) Introduction: the role of inflammation, autoimmune disease and infectious agents in development of leukaemia and lymphoma. J Intern Med 264:512\u2013513","journal-title":"J Intern Med"},{"key":"4621_CR5","volume-title":"Sj\u00f6gren\u2019s syndrome: an advisory guide for patients and doctors","author":"I Griffiths","year":"1993","unstructured":"Griffiths I, Kelly C (1993) Systemic features. In: Venables PJW (ed) Sj\u00f6gren\u2019s syndrome: an advisory guide for patients and doctors. Manor House Marketing, London"},{"key":"4621_CR6","doi-asserted-by":"publisher","first-page":"8409","DOI":"10.4049\/jimmunol.175.12.8409","volume":"175","author":"RH Scofield","year":"2005","unstructured":"Scofield RH, Asfa S, Obeso D, Jonsson R, Kurien BT (2005) Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sj\u00f6gren\u2019s syndrome. J Immunol 175:8409\u20138414","journal-title":"J Immunol"},{"key":"4621_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3238\/arztebl.2017.0354","volume":"26","author":"AL Stefanski","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T (2017) The diagnosis and treatment of Sj\u00f6gren\u2019s syndrome. Dtsch Arztebl Int 26:354\u2013361. \n                    https:\/\/doi.org\/10.3238\/arztebl.2017.0354","journal-title":"Dtsch Arztebl Int"},{"key":"4621_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jim\u00e9nez-Alonso J, Mic\u00f3 ML, Beltr\u00e1n J, Belenguer R, Pallar\u00e9s L, GEMESS Study Group (2008) GEMESS Study Group: primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 87:210\u2013219","journal-title":"Medicine"},{"key":"4621_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.276.5312.604","volume":"276","author":"N Haneji","year":"1997","unstructured":"Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of \u03b1-fodrin as a candidate autoantigen in primary Sj\u00f6gren\u2019s syndrome. Science 276:604\u2013607","journal-title":"Science"},{"key":"4621_CR10","first-page":"504","volume":"31","author":"A Ruffatti","year":"2004","unstructured":"Ruffatti A, Ostuni P, Grypiotis P, Botsios C, Tonello M, Grava C, Favaro M, Todesco S (2004) Sensitivity and specificity for primary Sj\u00f6gren\u2019s syndrome of IgA and IgG anti-\u03b1-fodrin antibodies detected by ELISA. J Rheumatol 31:504\u2013507","journal-title":"J Rheumatol"},{"key":"4621_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/ar1021","volume":"6","author":"MM Zandbelt","year":"2004","unstructured":"Zandbelt MM, Vogelzangs J, Van De Putte LB et al (2004) Anti-\u03b1-fodrin antibodies do not add much to the diagnosis of Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 6:33\u201338","journal-title":"Arthritis Res Ther"},{"key":"4621_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, the International Sj\u00f6gren\u2019s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69:35\u201345","journal-title":"Arthritis Rheumatol"},{"key":"4621_CR13","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T, Aletaha D, Silman AJ et al (2010) The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 62:2582\u20132591","journal-title":"Arthritis Rheum"},{"key":"4621_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<45::AID-IMMU45>3.0.CO;2-I","volume":"29","author":"MJ Deeths","year":"1999","unstructured":"Deeths MJ, Mescher MF (1999) ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur J Immunol 29:45\u201353","journal-title":"Eur J Immunol"},{"key":"4621_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3899\/jrheum.080733","volume":"36","author":"WS Chen","year":"2009","unstructured":"Chen WS, Lin KC, Chen CH et al (2009) Autoantibody and biopsy grading are associated with expression of ICAM-1, MMP-3, and TRAIL in salivary gland mononuclear cells of Chinese patients with Sjogren's syndrome. J Rheumatol 36:989\u2013996","journal-title":"J Rheumatol"},{"key":"4621_CR16","first-page":"1063","volume":"32","author":"N Turkcapar","year":"2005","unstructured":"Turkcapar N, Sak SD, Saatci M, Duman M, Olmez U (2005) Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjogren\u2019s syndrome. J Rheumatol 32:1063\u20131070","journal-title":"J Rheumatol"},{"key":"4621_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.17219\/acem\/61434","volume":"26","author":"K B\u0142ochowiak","year":"2017","unstructured":"B\u0142ochowiak K, Olewicz-Gawlik A, Trzybulska D et al (2017) Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sj\u00f6gren\u2019s syndrome. Adv Clin Exp Med 26:835\u2013842","journal-title":"Adv Clin Exp Med"},{"key":"4621_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/iop.2016.0105","volume":"33","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, Stern M, Zhang S, Shojaei A (2017) LFA-1\/ICAM-1 interaction as a therapeutic target in dry eye disease. J Ocul Pharm Therap 33:5\u201312. \n                    https:\/\/doi.org\/10.1089\/iop.2016.0105","journal-title":"J Ocul Pharm Therap"},{"key":"4621_CR19","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/ar2676","volume":"11","author":"CQ Nguyen","year":"2009","unstructured":"Nguyen CQ, Sharma A, Lee BH, She JX, McIndoe RA, Peck AB (2009) Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren\u2019s syndrome-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther 11:R56","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"4621_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3341\/jkos.2011.52.6.658","volume":"52","author":"C Won","year":"2011","unstructured":"Won C, Seung-Hyun L, Kyung-Chul Y (2011) Analysis of CCL5 concentration in tears of dry eye patients. J Korean Ophthalmol Soc 52(6):658\u2013664","journal-title":"J Korean Ophthalmol Soc"},{"key":"4621_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/ard.2007.077891","volume":"67","author":"NM Moutsopoulos","year":"2008","unstructured":"Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM (2008) Lack of efficacy of etanercept in Sj\u00f6gren syndrome correlates with failed suppression of tumour necrosis factor \u03b1 and systemic immune activation. Ann Rheum Dis 67:1437\u20131443","journal-title":"Ann Rheum Dis"},{"key":"4621_CR22","unstructured":"Tzec-P\u00e9rez A , Barbosa-Cobos RE , Lugo-Zamudio GE, et al (2016) Cytokine and chemokine levels in serum and saliva as disease activity biomarkers in patients with primary Sj\u00f6gren\u2019s syndrome Mexico Meeting: 2016 ACR\/ARHP Annual Meeting Date of 1rst publication: September 28, 2016"},{"key":"4621_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00296-018-4063-8","volume":"38","author":"P Olsson","year":"2018","unstructured":"Olsson P, Skogstrand K, Nilsson A, Turesson C, Jacobsson LTH, Theander E, Houen G, Mandl T (2018) Smoking, disease characteristics and serum cytokine levels in patients with primary Sj\u00f6gren\u2019s syndrome. Rheum Int 38:1503\u20131510","journal-title":"Rheum Int"},{"key":"4621_CR24","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1136\/annrheumdis-2013-203447","volume":"72","author":"RPE Pollard","year":"2013","unstructured":"Pollard RPE, Abdulahad WH, Bootsma H, Meiners PM, Spijkervet FKL, Huitema MG, Burgerhof JGM, Vissink A, Kroese FGM (2013) Predominantly pro-inflammatory cytokines decrease after b cell depletion therapy in patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 72:2048\u20132050. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-203447","journal-title":"Ann Rheum Dis"},{"key":"4621_CR25","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s00018-008-8646-5","volume":"66","author":"S Kjellev","year":"2008","unstructured":"Kjellev S (2008) The trefoil factor family-small peptides with multiple functionalities. Cell Mol Life Sci 66:1350\u20131369","journal-title":"Cell Mol Life Sci"},{"key":"4621_CR26","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1167\/iovs.13-13423","volume":"55","author":"U Schulze","year":"2014","unstructured":"Schulze U, Hampel U, Sel S, Contreras-Ruiz L, Schicht M, Dieckow J, Diebold Y, Paulsen F (2014) Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro. Invest Ophthalmol Vis Sci 55:3037\u20133042","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4621_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.proghi.2006.03.001","volume":"41","author":"F Paulsen","year":"2006","unstructured":"Paulsen F, Berry M (2006) Mucins and TFF peptides of the tear film and lacrimal apparatus. Prog Histochem Cytochem 41:1\u201353","journal-title":"Prog Histochem Cytochem"},{"issue":"4","key":"4621_CR28","first-page":"331","volume":"7","author":"Y Yildiz","year":"2013","unstructured":"Yildiz Y, Ozaksit G, Serdar Unlu B, Ozgu E, Energin H, Kaba M, Ugur M (2013) Serum adiponectin level and clinical, metabolic, and hormonal markers in patients with polycystic ovary syndrome. Int J Fertil Steril 7(4):331\u2013336","journal-title":"Int J Fertil Steril"},{"key":"4621_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/938408","volume":"2010","author":"E Toussirot","year":"2010","unstructured":"Toussirot E, Gaugler B, Bouhaddi M, Nguyen NU, Saas P, Dumoulin G (2010) Elevated adiponectin serum levels in women with systemic autoimmune diseases. Med Infl 2010:1\u20136. \n                    https:\/\/doi.org\/10.1155\/2010\/938408","journal-title":"Med Infl"},{"key":"4621_CR30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00784-018-2570-3","volume":"23","author":"A Tvarijonaviciute","year":"2018","unstructured":"Tvarijonaviciute A, Zamora C, Martinez-Subiela S, Tecles F, Pina F, Lopez-Jornet P (2018) Salivary adiponectin, but not adenosine deaminase, correlates with clinical signs in women with Sj\u00f6gren\u2019s syndrome: a pilot study. Clin Oral Invest 23:1407\u20131414. \n                    https:\/\/doi.org\/10.1007\/s00784-018-2570-3","journal-title":"Clin Oral Invest"},{"issue":"13","key":"4621_CR31","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"UB Pajvani","year":"2004","unstructured":"Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279(13):12152\u201312162","journal-title":"J Biol Chem"},{"issue":"10","key":"4621_CR32","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1210\/jc.2006-1158","volume":"91","author":"R Nakashima","year":"2006","unstructured":"Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N (2006) Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91(10):3873\u20133877","journal-title":"J Clin Endocrinol Metab"},{"issue":"6941","key":"4621_CR33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941):762\u2013769","journal-title":"Nature"},{"key":"4621_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-230X(08)60305-X","volume":"59","author":"C Basilico","year":"1992","unstructured":"Basilico C, Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115","journal-title":"Adv Cancer Res"},{"key":"4621_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.0300-9475.2004.01432.x","volume":"59","author":"P Szodoray","year":"2004","unstructured":"Szodoray P, Alexy P, Brun JG et al (2004) Circulating cytokines in primary Sj\u00f6gren\u2019s syndrome determined by a multiplex cytokine Array system. Scand J Immunol 59:592\u2013599","journal-title":"Scand J Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04621-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T23:27:52Z","timestamp":1590794872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04621-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4621"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04621-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"21 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Vilnius Regional Biomedical Research Ethics Committee (2014-05-20, No. 158200-14-733-248), and written consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}